Rhine R. Shen

Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene

Jesse S. Boehm, Jean J. Zhao, Jun Yao et al. · Cell · 2007 · 624 citations · Full text

Breast Oncology, Medicine, Cancer Genomics +8

Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study

Michael Wang, Javier Muñoz, André Goy et al. · Journal of Clinical Oncology · 2022 · 283 citations · Full text

Phosphorylation of the Tumor Suppressor CYLD by the Breast Cancer Oncogene IKKɛ Promotes Cell Transformation

Jessica E. Hutti, Rhine R. Shen, Derek W. Abbott et al. · Molecular Cell · 2009 · 227 citations · Full text

Signal Transduction, Cell Regulation, Medicine +9

5-Year Follow-Up Supports Curative Potential of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphoma (ZUMA-1)

Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi et al. · Blood · 2023 · 215 citations · Full text

Inhibition of <i>KRAS</i> -Driven Tumorigenicity by Interruption of an Autocrine Cytokine Circuit

Zehua Zhu, Amir Reza Aref, Travis J. Cohoon et al. · Cancer Discovery · 2014 · 190 citations · Full text